Share
Journal Information
Issue
Vol. 11. Issue 6.Pages 816-980 (November - December 2012)
Hepatology highlights
Concise review
Genomic determinants of hepatitis C virus antiviral therapy outcomes: toward individualized treatment
Mauricio Venegas, Javier Brahm, Rodrigo A. Villanueva
Ann Hepatol. 2012;11:827-37
Open access
Greater Celandine hepatotoxicity: a clinical review
Rolf Teschke, Christian Frenzel, Xaver Glass, Johannes Schulze, Axel Eickhoff
Ann Hepatol. 2012;11:838-48
Open access
Original article
Genotype/subgenotype distribution of hepatitis B virus among hemodialysis patients with chronical hepatitis B
Murat Sayan, Cengiz Dogan
Ann Hepatol. 2012;11:849-54
Open access
Validation and comparison of simple noninvasive models for the prediction of liver fibrosis in chronic hepatitis C
Thabata Glenda Fenili Amorim, Guilherme Jönck Staub, César Lazzarotto, André Pacheco Silva, Joice Manes, Maria da Graça Ferronato, Maria Beatriz Cacese Shiozawa, Janaína Luz Narciso-Schiavon, ... Leonardo de Lucca Schiavon
Ann Hepatol. 2012;11:855-61
Open access
Epidemiological, clinical and laboratory features of chronic hepatitis B infection in a cohort of immigrant and Italian patients from Ferrara, Italy
Carlo Contini, Lorenzo Badia, Rosario Cultrera, Anastasio Grilli, Aldo De Togni
Ann Hepatol. 2012;11:862-9
Open access
Occult HBV infection among anti-HBc positive HIV-infected patients in apex referral centre, Eastern India
R. Panigrahi, S. Majumder, M. Gooptu, A. Biswas, S. Datta, P.K. Chandra, A. Banerjee, S. Chakrabarti, ... R. Chakravarty
Ann Hepatol. 2012;11:870-5
Open access
IL28B polymorphisms predict the response to chronic hepatitis C virus infection treatment in a Mexican population
Laura E. Martínez-Gómez, Norberto C. Chávez-Tapia, Ana I. Burguete-García, Nancy Aguilar-Olivos, Vicente Madrid-Marina, Margarita Román-Bahena, Citlalli Orbe-Orihuela, Uribe Misael, Nahum Méndez-Sánchez
Ann Hepatol. 2012;11:876-81
Open access
Health-related quality of life in Egyptian patients after liver transplantation
Mahasen Mabrouk, Gamal Esmat, Ayman Yosry, Magdy El-Serafy, Wahid Doss, Naglaa Zayed, Medhat El-Sahhar, Sally Awny, Ashraf Omar
Ann Hepatol. 2012;11:882-90
Open access
Steatotic livers. Can we use them in OLTX? Outcome data from a prospective baseline liver biopsy study
Mauricio Gabrielli, Fabrizio Moisan, Marcela Vidal, Ignacio Duarte, Macarena Jiménez, Guillermo Izquierdo, Pilar Domínguez, Javier Méndez, ... Jorge Martínez
Ann Hepatol. 2012;11:891-8
Open access
Evaluation of the C3435T polymorphism in the MDR1 gene in patients with hepatocellular carcinoma
Vanessa Dido Baldissera, Angelo Alves de Mattos, Gabriela Perdomo Coral, Fernanda Branco de Araujo, Cláudio Augusto Marroni, Ajácio Bandeira de Mello Brandao, Paulo Roberto Ott Fontes, Carlos Thadeu Schmidt Cerski, ... Nélson Alexandre Kretzmann Filho
Ann Hepatol. 2012;11:899-906
Open access
Response to different therapeutic approaches in Wilson disease. A long-term follow up study
Beatriz Rodríguez, Juan Burguera, Marina Berenguer
Ann Hepatol. 2012;11:907-14
Open access
Prognostic factors associated with in-hospital mortality in patients with spontaneous bacterial peritonitis
Maiara Isabel Musskopf, Fabricio Pimentel Fonseca, Jeferson Gass, Angelo Zambam de Mattos, Jorge Alberto John, Ajacio Bandeira de Mello Brandao
Ann Hepatol. 2012;11:915-20
Open access
Splenectomy in cirrhosis with hypersplenism: improvement in cytopenias, child's status and institution of specific treatment for hepatitis C with success
Saurabh Kedia, Rohit Goyal, Vivek Mangla, Ajay Kumar, S. Shalimar, Prasenjit Das, Sujoy Pal, Peush Sahni, Subrat K. Acharya
Ann Hepatol. 2012;11:921-9
Open access
Bile acids content in brain of common duct ligated rats
Valeria Tripodi, Mario Contin, María Alejandra Fernández, Abraham Lemberg
Ann Hepatol. 2012;11:930-4
Open access
Protective role of standardized Feronia limonia stem bark methanolic extract against carbon tetrachloride induced hepatotoxicity
Mahendra Jain, Rakhee Kapadia, Ravirajsinh Navalsinh Jadeja, Menaka Chanu Thounaojam, Ranjitsinh Vijaysinh Devkar, Shri Hari Mishra
Ann Hepatol. 2012;11:935-43
Open access
Editorial
Alcohol effects on liver diseases: good or bad buddy?
Varenka J. Barbero-Becerra, Jorge A. López-Velázquez, Vicente Sánchez-Valle, Misael Uribe, Nahum Méndez-Sánchez
Ann Hepatol. 2012;11:944-8
Open access
Images in hepatology
An unusual cause of portal cavernomatosis
Fabrizio R. Moisan, José L. Galindo, Nicolás P. Jarufe
Ann Hepatol. 2012;11:949-50
Open access
Case report
Porphyria cutanea tarda in an HCV-positive liver transplant patient: a case report
Adriano M. Pellicelli, Aldo Morrone, Luca Barbieri, Arnaldo Andreoli
Ann Hepatol. 2012;11:951-4
Open access
Spontaneous bacterial peritonitis caused by Listeria monocytogenes: a case report and literature review
Cláudia Cardoso, Isabelle Cremers, Ana Paula Oliveira
Ann Hepatol. 2012;11:955-7
Open access
Dorsal root ganglionopathy in a hepatitis C patient: a case report
Navya Basavaraju, Mirza Ahmad, Eoin Slattery
Ann Hepatol. 2012;11:958-60
Open access
Thyroid-like cholangiocarcinoma of the liver: an unusual morphologic variant with follicular, trabecular and insular patterns
Fredy Chablé-Montero, Amy Shah BS, Daniel Montante-Montes de Oca, Arturo Ángeles-Ángeles, Donald E. Henson, Jorge Albores-Saavedra
Ann Hepatol. 2012;11:961-5
Open access
Letter to editor
Elevated alanine aminotransferase levels are associated with impaired fasting glucose and type 2 diabetes in obese women
Heriberto Rodríguez-Hernández, Luis E. Simental-Mendía, Carmen Bermúdez-Peña, Graciela Zambrano-Galván, Martha Rodríguez-Morán, Fernando Guerrero-Romero
Ann Hepatol. 2012;11:966
Open access
Liver news elsewhere
Special notice
Index to volume
Publish in
Annals of Hepatology
Special content about COVID-19
- Outcomes and factors associated with relapse of vaccine-induced liver injury after SARS CoV-2 immunization: A nationwide study
- Matrix metalloproteinase-2 inducing COL1A1 synthesis via integrin alpha Ⅴ promotes invasion and metastasis of cholangiocarcinoma cells
- P-2 NASH IS IMPROVED THROUGH MODIFICATIONS IN H3K9 METHYLATION BY PIRFENIDONE ACTING AS JMJD2B DEMETHYLASE ANTAGONIST.
- O-2 EVALUATION OF RISK FACTORS AND PROGNOSIS OF HEPATOCELLULAR CARCINOMA RECURRENCE AFTER LIVER TRANSPLANTATION
Affiliated societies
